General Information
Endo Low Back Pain 201
A Phase IIb, Randomized, Double-Blind, Two-Arm, Multi-Center, Placebo-Controlled Study To Assess The Efficacy and Safety of En3324 (Axomadol) In Subjects With Moderate To Severe Chronic Low Back Pain
| Protocol | EN3324-201 |
|---|---|
| Identifier | EN3324-201 |
| UID | 8776b20f-1ca7-4f4d-8a1d-1c7ec2b59ffe |
| Status | Done - Archived |
| Phase | 2b |
| Category | Low Back Pain / Adult |
| Launch Year | 2010 |
| NCT Number | - |
| Created | 2010-05-10 17:19 |
| Last Updated | 2010-05-10 17:19 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2010-11-12 | No |
| Enrollment Open | 2010-04-06 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2011-07-27 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohaupt, Stephen | SMohaupt | No |
| Recruiter | - | No | |
| Coordinator | Soler, Daniel | DSoler | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Endo Pharmaceuticals, Inc |
|---|---|
| Division | Endo Pharmaceuticals, Inc |
| Team | Endo Pharmaceuticals, Inc |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Inc Research, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
